EGFR and familial pancreatic carcinoma: In conclusion, our study suggests that pancreatic cancer cells actively respond to short-term gemcitabine stress by inducing invasion via up-regulating HAb18G/CD147 and activating downstream EGFR-pSTAT3 signaling.